Page
%P
2 Result(s)
within
Georg Gdynia
Antibodies
-
Article
Open AccessIdentification of BCL-XL as highly active survival factor and promising therapeutic target in colorectal cancer
Since metastatic colorectal cancer (CRC) is a leading cause of cancer-related death, therapeutic approaches overcoming primary and acquired therapy resistance are an urgent medical need. In this study, the eff...
-
Article
Open AccessBcl-xL is an oncogenic driver in colorectal cancer
Colorectal cancer (CRC) is the second most common malignant neoplasia in women and men worldwide. The B-cell lymphoma 2 (Bcl-2) protein family is mainly known for its pivotal role in the regulation of the mito...
